Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)

46.89
Delayed Data
As of Aug 04
 -0.73 / -1.53%
Today’s Change
10.45
Today|||52-Week Range
52.90
+18.08%
Year-to-Date
No recent news for Tetraphase Pharmaceuticals Inc.

Today’s Trading

Previous close47.62
Today’s open47.76
Day’s range46.66 - 48.26
Volume263,483
Average volume (3 months)460,169
Market cap$1.7B
Dividend yield--
Data as of 08/04/2015

Growth & Valuation

Earnings growth (last year)-39.89%
Earnings growth (this year)-3.29%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)-13.24%
P/E ratioNM
Price/Sales117.00
Price/Book13.49

Competitors

 Today’s
change
Today’s
% change
MNKDMannkind Corp-0.01-0.24%
PTCTPTC Therapeutics Inc-2.12-4.09%
ZIOPZIOPHARM Oncology In...-0.17-1.25%
INSMInsmed Inc-0.07-0.26%
Data as of 08/04/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$9.1M
Annual profit (last year)-$66.7M
Net profit margin-733.59%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Guy MacDonald
Chief Operating Officer
John Craig Thompson
Corporate headquarters
Watertown, Massachusetts

Forecasts